| Grove Manor | |
| 435 North Broad Street, Grove City, Pennsylvania 16127 | |
| (412) 458-7800 | |
| Name | Grove Manor |
|---|---|
| Location | 435 North Broad Street, Grove City, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 59 |
| Occupancy Rate | 60.68% |
| Medicare ID (CCN) | 395510 |
| Legal Business Name | Grove Manor Corporation |
| Ownership Type | Non Profit - Church Related |
| NPI Number | 1265504369 |
| Organization Name | GROVE MANOR CORPORATION |
| Doing Business As | GROVE MANOR CORPORATION |
| Address | 435 N Broad St, Grove City, PA 16127 |
| Phone Number | 724-958-7800 |
News Archive
An online training module designed for the evaluation and care of chronic pain greatly improved medical student clinical skills, according to a report in the Journal of the American Geriatrics Society.
Researchers have discovered three new inhibitors of insulin-regulated aminopeptidase (IRAP), compounds shown to improve cognitive functions in animal models of human disorders.
The human brain has some remarkable capabilities - including the ability to block cancer drugs from effectively reaching cancer cells in the brain.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced today that it expanded its patent portfolio with additional patents covering worldwide rights to develop and commercialize NeuVax.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
An online training module designed for the evaluation and care of chronic pain greatly improved medical student clinical skills, according to a report in the Journal of the American Geriatrics Society.
Researchers have discovered three new inhibitors of insulin-regulated aminopeptidase (IRAP), compounds shown to improve cognitive functions in animal models of human disorders.
The human brain has some remarkable capabilities - including the ability to block cancer drugs from effectively reaching cancer cells in the brain.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced today that it expanded its patent portfolio with additional patents covering worldwide rights to develop and commercialize NeuVax.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.45 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.86 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 78 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.87 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 7.33 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 5.33 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 22.13 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.61 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 0.74 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 80.97 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 100 | 82.93 |
News Archive
An online training module designed for the evaluation and care of chronic pain greatly improved medical student clinical skills, according to a report in the Journal of the American Geriatrics Society.
Researchers have discovered three new inhibitors of insulin-regulated aminopeptidase (IRAP), compounds shown to improve cognitive functions in animal models of human disorders.
The human brain has some remarkable capabilities - including the ability to block cancer drugs from effectively reaching cancer cells in the brain.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced today that it expanded its patent portfolio with additional patents covering worldwide rights to develop and commercialize NeuVax.
› Verified 7 days ago
Quality Life Services - Grove City Location: 400 Hillcrest Avenue, Grove City, Pennsylvania 16127 Phone: (724) 458-9501 | |